Cargando…
Mannose treatment improves immune deficiency in mannose phosphate isomerase–congenital disorder of glycosylation: case report and review of literature
Mannose phosphate isomerase–congenital disorder of glycosylation (MPI-CDG) is a CDG presenting with a clinically recognizable presentation, including early hypoglycemia, coagulation defects, and gastrointestinal and hepatic symptoms. We report on a female patient with biallelic pathogenic mutations...
Autores principales: | De Graef, Diederik, Mousa, Jehan, Waberski, Marta Biderman, Morava, Eva |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10032425/ https://www.ncbi.nlm.nih.gov/pubmed/37180423 http://dx.doi.org/10.1177/26330040221091283 |
Ejemplares similares
-
Congenital disorder of glycosylation – one size does not fit all: a parent’s
perspective
por: Feinberg, Konstantin
Publicado: (2022) -
Novel insights into the phenotype and long-term D-gal treatment in
PGM1-CDG: a case series
por: Radenkovic, Silvia, et al.
Publicado: (2023) -
Left-sided valvular heart disease and retinopathy in a 38-year-old
woman with attenuated mucopolysaccharidosis: a case report
por: Asumda, Faizal Z., et al.
Publicado: (2023) -
Clinical outcomes in an adult patient with mannose phosphate isomerase-congenital disorder of glycosylation who discontinued mannose therapy
por: Noman, Kinza, et al.
Publicado: (2020) -
Mannose phosphate isomerase gene mutation leads to a congenital disorder of glycosylation: A rare case report and literature review
por: Lu, Siliang, et al.
Publicado: (2023)